BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 11158332)

  • 1. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
    Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
    Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of transcriptional sensitivity of mineralocorticoid and estrogen receptors.
    Wang Q; Anzick S; Richter WF; Meltzer P; Simons SS
    J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):197-210. PubMed ID: 15336697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
    Cho S; Blackford JA; Simons SS
    Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
    Szapary D; Huang Y; Simons SS
    Mol Endocrinol; 1999 Dec; 13(12):2108-21. PubMed ID: 10598585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
    Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
    Wang D; Simons SS
    Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
    Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
    Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.
    Wagner BL; Norris JD; Knotts TA; Weigel NL; McDonnell DP
    Mol Cell Biol; 1998 Mar; 18(3):1369-78. PubMed ID: 9488452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
    Wardell SE; Edwards DP
    Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914.
    Attardi BJ; Burgenson J; Hild SA; Reel JR; Blye RP
    Mol Cell Endocrinol; 2002 Feb; 188(1-2):111-23. PubMed ID: 11911951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene.
    van der Laan S; Lachize SB; Vreugdenhil E; de Kloet ER; Meijer OC
    Endocrinology; 2008 Feb; 149(2):725-32. PubMed ID: 18006628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A; Garside H; Berry A; Waters C; White A; Ray D
    Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.
    Giangrande PH; Kimbrel EA; Edwards DP; McDonnell DP
    Mol Cell Biol; 2000 May; 20(9):3102-15. PubMed ID: 10757795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression.
    Tao YG; Xu Y; Xu HE; Simons SS
    Biochemistry; 2008 Jul; 47(29):7648-62. PubMed ID: 18578507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.
    Wardell SE; Narayanan R; Weigel NL; Edwards DP
    Mol Endocrinol; 2010 Feb; 24(2):335-45. PubMed ID: 20008003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors.
    Wang D; Wang Q; Awasthi S; Simons SS
    Biochemistry; 2007 Jul; 46(27):8036-49. PubMed ID: 17571860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.
    Tetel MJ; Giangrande PH; Leonhardt SA; McDonnell DP; Edwards DP
    Mol Endocrinol; 1999 Jun; 13(6):910-24. PubMed ID: 10379890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.